Role of a Web-Based Interactive Patient-Professional Support System (WIPPS) in the adherence of the Novel Oral Anti-Coagulants: a randomized controlled trial.
Withdrawn
- Conditions
- atrial fibrillationheart arrythmia10007521
- Registration Number
- NL-OMON38596
- Lead Sponsor
- stichting Begeleide Zelfzorg
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Withdrawn
- Sex
- Not specified
- Target Recruitment
- 600
Inclusion Criteria
- Age18 and above
- Patients diagnosed with atrial fibrillation who have a CHADS2-score of 2 or higher, or CHADS-2VASc-score of 1 or higher
- Patients must be able to communicate with the nurse or physician through the web-based system.
- Patients must have a medical indiaction as endorsed by the treating medical specialist to switch to or start with Rivaroxaban
Exclusion Criteria
- Younger than 18 years of age
- Not fluent in Dutch
- Pregnancy
- Life expectancy less than one year
- Reduced cognitive capacity
- Most recent creatinin clearance (24 hour creatinin clearance) less than 30 ml/min
- NYHA class III of IV heart failure
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Primary outcome is the percentage of compliant patients. Compliance of<br /><br>individual patients is usually reported as the percentage of the prescribed<br /><br>doses of the medication actually taken by the patient over a specified period<br /><br><br /><br>Compliance in the trial will be measured by The Medication Possession Rate<br /><br>(MPR). The MPR is calculated by dividing the number of days for which<br /><br>medication has been suplied by the number of days between refills at the<br /><br>pharmacist. As patients can pick up medication before they run out, compliance<br /><br>can be over 100%. A patient is considered compliant or adherent when MPR = 80%<br /><br>- 120%.</p><br>
- Secondary Outcome Measures
Name Time Method <p>Patient satisfaction. This will be measured, using a custom-made questionnaire,<br /><br>regarding aspects of care tailored to patients using anticoagulant medication.</p><br>